Integrated microbiome and metabolome analysis reveals that zishen qingre lishi huayu recipe regulates gut microbiota and butyrate metabolism to ameliorate polycystic ovary syndrome

Apr 4, 2025Microbial pathogenesis

Combined gut bacteria and metabolism analysis shows Zishen Qingre Lishi Huayu recipe improves polycystic ovary syndrome by adjusting gut microbes and butyrate metabolism

AI simplified

Circadian Biology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Zishen Qingre Lishi Huayu recipe (ZQLHR) significantly improved PCOS symptoms in patients.

ZQLHR treatment was associated with increased levels of butyrate-producing bacteria, specifically Lachnospira and Faecalibacterium.
A decrease in the abundance of Escherichia-Shigella was observed following ZQLHR treatment.
Untargeted metabolomics indicated that ZQLHR significantly enhanced host metabolic functions, particularly in butyrate and citrate cycle metabolism.
In a mouse model, stool samples from ZQLHR patients improved ovarian architecture and altered hormone levels, including a reduction in testosterone and estradiol and an increase in follicle-stimulating hormone.
Correlations were found between certain hormone levels and butyric acid, suggesting a link between gut microbiota and hormonal regulation.

AI simplified

BACKGROUND: Polycystic ovary syndrome (PCOS) is a metabolic disorder disease strongly associated with gut microbiota (GM). Zishen Qingre Lishi Huayu recipe (ZQLHR), a traditional Chinese medicinal compound, has patented and shown therapeutic effects in treating PCOS in clinical trials without clear pharmacological mechanisms. This study aimed to disclose the potential therapeutic mechanism of ZQLHR on PCOS.

METHODS: We firstly confirmed the therapeutic effects of ZQLHR treatment in PCOS patients. 16 S rRNA sequencing, untargeted metabolomics, fecal microbiota transplantation (FMT), high performance liquid chromatography (HPLC) and Person's correlation analysis were conducted to elucidate the potential therapeutic mechanism.

RESULTS: These results showed that PCOS symptoms in ZQLHR patients were significantly ameliorated. ZQLHR could increase the levels of butyrate-producing Lachnospira and Faecalibacterium and decrease the abundance of Escherichia-Shigella. Untargeted metabolomics showed that ZQLHR significantly improved host metabolic function, particularly butyrate metabolism and citrate cycle (TCA cycle) metabolism. The combined Faecalibacterium and butyrate metabolism datasets were correlated. Stool samples from ZQLHR patients could ameliorate ovarian architecture, significantly reduce testosterone (T), estradiol (E) and luteinizing hormone (LH) levels and increased follicle-stimulating hormone (FSH) levels and increase the content of butyric acid in PCOS mice (P < 0.01). Moreover, the correlation analysis showed that some biochemical parameters (T, E, LH levels and FSH) and butyric acid were correlated. 2 2

CONCLUSION: We firstly depicted that ZQLHR could alleviate the series of symptom in women with PCOS by regulating gut microbiota and butyrate metabolism. This study provides a scientific basis and new ideas for the therapy of PCOS.

Full Text

Full text is available at the source.

View full text (XML) ↗View full text ↗

Integrated microbiome and metabolome analysis reveals that zishen qingre lishi huayu recipe regulates gut microbiota and butyrate metabolism to ameliorate polycystic ovary syndrome

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the circadian biology brief